PROGESTERONE THERAPY FOR WOMEN WITH EPLILEPSY

女性癫痫患者的黄体酮治疗

• 批准号: 7982129
• 负责人: LAURA A KALAYJIAN
• 金额: $ 10.09万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7982129
• 关键词: Clinical Research; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Double-Blind Method; Frequencies; Funding; Goals; Grant; Institution; Partial Epilepsies; Placebos; Progesterone; Randomized; Research; Research Personnel; Resources; Seizures; Source; United States National Institutes of Health; Woman; comparative efficacy; trial comparing

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The specific goal is to complete a randomized, plecebo-controlled, double-blind multicenter clinical trial that compares the efficacy of cyclic adjunctive therapy using natural progesterone versus placebo in providing a clinically important decrease in the frequency of intractable seizures in women with localization-relate epilepsy.

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 具体目标是完成一项随机、plecebo对照、双盲、多中心临床试验，比较使用天然孕酮与安慰剂的周期性连续治疗在降低局部相关性癫痫女性难治性癫痫发作频率方面的临床重要作用。